Effects of kava alkaloid, pipermethystine, and kavalactones on oxidative stress and cytochrome P450 in F-344 rats - PubMed (original) (raw)
Comparative Study
doi: 10.1093/toxsci/kfm035. Epub 2007 Feb 27.
Affiliations
- PMID: 17329236
- DOI: 10.1093/toxsci/kfm035
Comparative Study
Effects of kava alkaloid, pipermethystine, and kavalactones on oxidative stress and cytochrome P450 in F-344 rats
Steven T S Lim et al. Toxicol Sci. 2007 May.
Abstract
Kava-containing products remain popular in the United States and continue to be sold in health food stores and ethnic markets regardless of the fact that it was banned in Western countries such as Germany, France, Switzerland, Australia, and Canada, following reports of alleged hepatotoxicity. It is therefore critical to establish efficacy and verify adverse effects and/or herb-drug interactions for kava-kava (Piper methysticum). We have previously demonstrated that kava alkaloid, pipermethystine (PM), abundant in leaves and stem peelings, induces mitochondrial toxicity in human hepatoma cells, HepG2, as compared with the bioactive components, kavalactones (KL), abundant in the rhizome. The current study compared short-term toxic effects of PM in Fischer-344 (F-344) rats to acetone-water extracts of kava rhizome (KRE). Treatment of F-344 rats with PM (10 mg/kg) and KRE (100 mg/kg) for 2 weeks failed to elicit any significant changes in liver function tests or cause severe hepatic toxicity as measured by lipid peroxidation and apoptosis markers such as malondialdehyde, Bax, and Bcl-2. However, PM-treated rats demonstrated a significant increase in hepatic glutathione, cytosolic superoxide dismutase (Cu/ZnSOD), tumor necrosis factor alpha mRNA expression, and cytochrome P450 (CYP) 2E1 and 1A2, suggesting adaptation to oxidative stress and possible drug-drug interactions.
Similar articles
- In vitro toxicity of kava alkaloid, pipermethystine, in HepG2 cells compared to kavalactones.
Nerurkar PV, Dragull K, Tang CS. Nerurkar PV, et al. Toxicol Sci. 2004 May;79(1):106-11. doi: 10.1093/toxsci/kfh067. Epub 2004 Jan 21. Toxicol Sci. 2004. PMID: 14737001 - High dose of commercial products of kava (Piper methysticum) markedly enhanced hepatic cytochrome P450 1A1 mRNA expression with liver enlargement in rats.
Yamazaki Y, Hashida H, Arita A, Hamaguchi K, Shimura F. Yamazaki Y, et al. Food Chem Toxicol. 2008 Dec;46(12):3732-8. doi: 10.1016/j.fct.2008.09.052. Epub 2008 Sep 30. Food Chem Toxicol. 2008. PMID: 18930106 - Is the alkaloid pipermethystine connected with the claimed liver toxicity of Kava products?
Lechtenberg M, Quandt B, Schmidt M, Nahrstedt A. Lechtenberg M, et al. Pharmazie. 2008 Jan;63(1):71-4. Pharmazie. 2008. PMID: 18271308 - Pharmacokinetic and pharmacodynamic drug interactions with Kava (Piper methysticum Forst. f.).
Anke J, Ramzan I. Anke J, et al. J Ethnopharmacol. 2004 Aug;93(2-3):153-60. doi: 10.1016/j.jep.2004.04.009. J Ethnopharmacol. 2004. PMID: 15234747 Review. - Kava kava: examining new reports of toxicity.
Clouatre DL. Clouatre DL. Toxicol Lett. 2004 Apr 15;150(1):85-96. doi: 10.1016/j.toxlet.2003.07.005. Toxicol Lett. 2004. PMID: 15068826 Review.
Cited by
- Review of Scientific Evidence of Medicinal Convoy Plants in Traditional Persian Medicine.
Sadati SN, Ardekani MR, Ebadi N, Yakhchali M, Dana AR, Masoomi F, Khanavi M, Ramezany F. Sadati SN, et al. Pharmacogn Rev. 2016 Jan-Jun;10(19):33-8. doi: 10.4103/0973-7847.176546. Pharmacogn Rev. 2016. PMID: 27041871 Free PMC article. Review. - Dietary feeding of Flavokawain A, a Kava chalcone, exhibits a satisfactory safety profile and its association with enhancement of phase II enzymes in mice.
Li X, Xu X, Ji T, Liu Z, Gu M, Hoang BH, Zi X. Li X, et al. Toxicol Rep. 2014;1:2-11. doi: 10.1016/j.toxrep.2014.02.002. Toxicol Rep. 2014. PMID: 25379458 Free PMC article. - Flavokawain B, the hepatotoxic constituent from kava root, induces GSH-sensitive oxidative stress through modulation of IKK/NF-kappaB and MAPK signaling pathways.
Zhou P, Gross S, Liu JH, Yu BY, Feng LL, Nolta J, Sharma V, Piwnica-Worms D, Qiu SX. Zhou P, et al. FASEB J. 2010 Dec;24(12):4722-32. doi: 10.1096/fj.10-163311. Epub 2010 Aug 9. FASEB J. 2010. PMID: 20696856 Free PMC article. - Liver toxicity and carcinogenicity in F344/N rats and B6C3F1 mice exposed to Kava Kava.
Behl M, Nyska A, Chhabra RS, Travlos GS, Fomby LM, Sparrow BR, Hejtmancik MR, Chan PC. Behl M, et al. Food Chem Toxicol. 2011 Nov;49(11):2820-9. doi: 10.1016/j.fct.2011.07.067. Epub 2011 Aug 18. Food Chem Toxicol. 2011. PMID: 21871523 Free PMC article. - Hepatotoxicity Induced by "the 3Ks": Kava, Kratom and Khat.
Pantano F, Tittarelli R, Mannocchi G, Zaami S, Ricci S, Giorgetti R, Terranova D, Busardò FP, Marinelli E. Pantano F, et al. Int J Mol Sci. 2016 Apr 16;17(4):580. doi: 10.3390/ijms17040580. Int J Mol Sci. 2016. PMID: 27092496 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials